Roche may delay launch Alnylam pauses study Relay delays launch Seagen cancels study Bristol Myers discontinues study Novartis delays launch Drugmakers are “openly saying ‘We have this product that ...
Greetings and welcome to Rigel Pharmaceutical's Financial Conference Call for the Third Quarter 2024. At this time, all participants are in a listen-only mode. A brief question and answer session will ...
Pain makes you miserable. And I should know. For the past 15 years, I've suffered from sciatica, as well as swollen ankles and feet caused partly by arthritis.
New data for investigational nipocalimab in Sjögren's Disease (SjD) and new research on the impact of TREMFYA® (guselkumab) in psoriatic arthritis (PsA) will be highlighted across three oral sessions ...